Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Alnylam Pharmaceuticals has commenced clinical trials for a second obesity candidate targeting the INHBE gene, joining a competitive race alongside Wave Life Sciences and Arrowhead Pharmaceuticals. Simultaneously, Novo Holdings is ... Read More
Continuous Coverage
There is a particular rhythm to the Bali travel cycle—a dance between the island’s desperate need for high-volume…
Dr. Amara Kante, a University of British Columbia (UBC) infectious disease specialist, has joined the World Health Organization’s…
The Eastern Province Rugby Union (EPRU) is currently embroiled in a volatile selection controversy following the recent Youth…
When Bokang Montjane-Tshabalala secured the rights to Miss World, Miss Universe and Miss Supranational in South Africa, she…
Gulf equity markets finished the trading session with mixed results as investors recalibrated positions amid shifting geopolitical sentiment…
Israel and Lebanon have tentatively agreed to a ceasefire brokered by U.S. And UN mediators, raising hopes of…
Global Affairs
Las Vegas Sands Corp. Received a neutral rating from UBS on June 4, 2026, signaling cautious optimism amid…
Markets And Money
On June 3, 2026, lottery operators across Latin America, including Mexico’s Melate and the Lotería Nacional de Panamá,…
Digital Culture
Eastern Acoustic Works (EAW) has officially launched the NT116S, a 16-inch powered subwoofer engineered for high-output, low-frequency reinforcement.…
Science And Wellbeing
Oura Health, the Finnish developer of the Oura Ring, is accelerating toward a potential Initial Public Offering (IPO)…
Screen And Sound
On Thursday morning, June 4, 2026, Brazilian journalist Ana Paula Santos executed a high-stakes transition at Globo’s Rio…
Fixtures And Form
The 48 national teams qualified for the 2026 FIFA World Cup have unveiled their official matchday kits, blending…
